Profiel
John Valliant is the founder of the Centre For Probe Development & Commercialization, holding the title of Independent Director & Principal Investigator since 2008.
Dr. Valliant was the founder of Fusion Pharmaceuticals, Inc., having held the title of Chief Executive Officer & Director from 2014 to 2024.
Dr. Valliant's current job is as a Professor at McMaster University, starting in 1999.
Dr. Valliant's education includes a doctorate from McMaster University.
Actieve functies van John Valliant
| Bedrijven | Functie | Begin |
|---|---|---|
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Oprichter | 01-03-2008 |
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-1999 |
Eerdere bekende functies van John Valliant
| Bedrijven | Functie | Einde |
|---|---|---|
| FUSN PHAR | Oprichter | 04-06-2024 |
Opleiding van John Valliant
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fusion Pharmaceuticals, Inc.
Fusion Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals for the treatment of cancer | Health Technology |
Centre For Probe Development & Commercialization
Centre For Probe Development & Commercialization Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes radiopharmaceuticals for early diagnosis and treatment of diseases | Health Technology |
















